Phorum™ (Postbiotic — BIOHM)

Evidence Level
Preliminary
1 Clinical Trial
4 Documented Benefits
1/5 Evidence Score

Phorum™ is a branded postbiotic from BIOHM Technologies, made from heat-treated (non-living) probiotic strains: Lactobacillus acidophilus 16axg, Lacticaseibacillus rhamnosus 18fx, and the yeast Saccharomyces cerevisiae var. boulardii 16mxg. Postbiotics are inactivated microbes and their cell fragments, so they are shelf-stable and do not need to be kept alive. Phorum's entire evidence base is one laboratory study, sponsored in part by BIOHM Health, LLC and co-authored by a founding partner of that company, in which the heat-killed strains were added to human monocytes (a type of white blood cell) in culture and the cells increased their output of cytokines. No published study has given Phorum to a person, so no immune outcome, no illness or infection data and no gut outcome have been measured in anyone. The manufacturer says a human study in active adults is underway; it is unpublished and has no ClinicalTrials.gov registration, so it is not evidence.

Studied Dose No dose has been studied in people. The manufacturer's stated use level is 20 mg/day (about 1.1 billion non-living cells).
Active Compound Heat-treated (tyndallized) cells and cell-wall fragments of Lactobacillus acidophilus 16axg, Lacticaseibacillus rhamnosus 18fx, and Saccharomyces cerevisiae var. boulardii 16mxg (postbiotic).

Benefits

Immune cell signaling in a laboratory dish

In one laboratory study, heat-killed Phorum strains were added to human CD14+ monocytes (a type of white blood cell) in culture, and the cells raised their production of cytokines, the signaling proteins immune cells use to communicate. That is activity in a dish, not a health benefit. The cells were blood monocytes, not gut tissue, so nothing in this work touched the gut. Higher cytokine output is inflammatory signaling, and whether it helps a person, does nothing, or is unwanted has not been tested, because no one has taken Phorum in a published study.

Non-living cells, with no human testing

Because postbiotics are inactivated, they deliver immune-signaling cell fragments without needing living organisms to survive digestion. No study has tested whether people who tolerate live probiotics poorly do better on Phorum, and no study has measured it engaging the gut immune system in a person.

Shelf-stable and consistent

Postbiotics stay active without refrigeration and hold up across a wide range of formats and formulations, so a consistent daily dose is easier to deliver and store than with many live probiotic products.

Built on well-characterized strains

Phorum uses the same Lactobacillus and Saccharomyces strains studied in BIOHM's probiotic work, applied here in a heat-killed form. Those earlier studies tested the live organisms in a different blend that also contained Bifidobacterium breve 19bx and alpha-amylase, so their results do not carry over to this product.

Mechanism of action

1

Postbiotic immune signaling

Fragments of the heat-killed microbes, such as cell-wall peptidoglycans and polysaccharides, are recognized by pattern-recognition receptors on immune cells, which is the proposed route by which a non-living postbiotic could act without needing to colonize the gut. This has not been shown in anyone taking Phorum.

2

Cytokine induction in monocytes

In isolated human CD14+ monocytes, the heat-killed strains raised cytokine gene and protein expression. The two bacteria were similarly stimulatory, and heat-killed S. boulardii alone was less stimulatory than the bacteria at the same concentration, although adding the yeast to the two bacteria increased stimulation further. This is cell-culture activity only, and raised cytokine output is inflammatory signaling whose value in a living person has not been measured.

3

Tyndallized (heat-killed) cells

Controlled heat treatment inactivates the organisms while preserving their bioactive cell structures, giving the stability and safety of a postbiotic while retaining the immune-signaling surface molecules.

Clinical trials

1
Laboratory Cell Study, Not a Trial in People: Phorum Strains Added to Isolated Human Immune Cells
PubMed

Laboratory study of the Phorum postbiotic strains (heat-killed L. acidophilus 16axg, L. rhamnosus 18fx and S. cerevisiae var. boulardii 16mxg) on cytokine production by human CD14+ monocytes in culture (Roberts et al., Life, 2024). No people took the product. The work was sponsored in part by a grant from BIOHM Health, LLC and the senior author is a founding partner of the company. The manufacturer says a human study in active adults is underway; it is unpublished and no ClinicalTrials.gov registration for it could be located.

Not people: human CD14+ monocytes in cell culture.

Heat-killed L. acidophilus and L. rhamnosus both stimulated naive monocytes to produce cytokines, with no significant difference between them. Heat-killed S. boulardii produced less cytokine stimulation than the bacteria at the same concentration, but adding the yeast to the two bacteria increased stimulation further. All of this happened in cell culture, so no clinical outcome was measured. Human efficacy outcomes have not yet been published.

Side effects and drug interactions

Common Potential side effects

No human tolerability or safety data exist for Phorum itself. Postbiotics as a class contain no living organisms, and inactivated microbial cells are generally regarded as low risk.
Because the cells are inactivated, the infection risks tied to live probiotics do not apply.
Mild, temporary digestive changes are possible when starting any new gut supplement.
There are no published human safety or efficacy data for Phorum at all. The manufacturer reports an unpublished study underway.

Important Drug interactions

Immunosuppressants: an immune-stimulating postbiotic could in theory work against them; use cautiously if immunosuppressed.
No significant interactions are expected, since the product contains no living organisms or active drugs.
As with any supplement, tell your doctor if you take prescription medication or manage a health condition.

Frequently asked questions about Phorum™ (Postbiotic — BIOHM)

What is Phorum?

Phorum™ is a branded postbiotic from BIOHM Technologies, made from heat-treated (non-living) probiotic strains: Lactobacillus acidophilus 16axg, Lacticaseibacillus rhamnosus 18fx, and the yeast Saccharomyces cerevisiae var. boulardii 16mxg.

What is Phorum used for?

Phorum is researched primarily for Immune Support. In one laboratory study, heat-killed Phorum strains were added to human CD14+ monocytes (a type of white blood cell) in culture, and the cells raised their production of cytokines, the signaling proteins immune cells use to communicate.

What is the recommended dosage of Phorum?

No dose has been studied in people. The manufacturer's stated use level is 20 mg/day (about 1.1 billion non-living cells). Always follow the product label and check with a healthcare provider for personal advice.

Is Phorum safe, and does it have side effects?

Side effects and cautions reported for Phorum include: No human tolerability or safety data exist for Phorum itself. Postbiotics as a class contain no living organisms, and inactivated microbial cells are generally regarded as low risk. Because the cells are inactivated, the infection risks tied to live probiotics do not apply. It may also interact with some medications. Phorum is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Phorum interact with any medications?

Possible interactions include: Immunosuppressants: an immune-stimulating postbiotic could in theory work against them; use cautiously if immunosuppressed. No significant interactions are expected, since the product contains no living organisms or active drugs. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Phorum?

NutraSmarts rates the evidence for Phorum as Preliminary (1 out of 5). It is backed by 1 study summary and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Roberts KD, Ahmed S, San Valentin E, Di Martino L, McCormick TS, Ghannoum MA. Immunomodulatory Properties of Multi-Strain Postbiotics on Human CD14(+) Monocytes. Life (Basel). 2024;14(12):1673. doi: 10.3390/life14121673.PubMedUsed to support: Cell-culture study, not a study in people: heat-killed L. acidophilus 16axg and L. rhamnosus 18fx were added to human CD14+ monocytes in the laboratory and both raised cytokine gene and protein expression, with no significant difference between the two bacteria. Heat-killed S. cerevisiae var. boulardii 16mxg stimulated less cytokine production than the bacteria at the same concentration, but adding the yeast to the two bacteria increased stimulation further. No immune, gut or clinical outcome was measured in a person. The work was sponsored in part by a grant from BIOHM Health, LLC and the senior author is a founding partner of the company.